Silencing of Atp6v1c1 Prevents Breast Cancer Growth and Bone Metastasis

Previous studies have shown that Atp6v1c1, a regulator of the assembly of the V0 and V1 domains of the V-ATPase complex, is up-regulated in metastatic oral tumors. Despite these studies, the function of Atp6v1c1 in tumor growth and metastasis is still unknown. Atp6v1c1's expression in metastatic oral squamous cell carcinoma indicates that Atp6v1c1 has an important function in cancer growth and metastasis. We hypothesized that elevated expression of Atp6v1c1 is essential to cancer growth and metastasis and that Atp6v1c1 promotes cancer growth and metastasis through activation of V-ATPase activity. To test this hypothesis, a Lentivirus-mediated RNAi knockdown approach was used to study the function of Atp6v1c1 in mouse 4T1 mammary tumor cell proliferation and migration in vitro and cancer growth and metastasis in vivo. Our data revealed that silencing of Atp6v1c1 in 4T1 cancer cells inhibited lysosomal acidification and severely impaired 4T1 cell growth, migration, and invasion through Matrigel in vitro. We also show that Atp6v1c1 knockdown with Lenti-c1s3, a lentivirus targeting Atp6v1c1 for shRNA mediated knockdown, can significantly inhibit 4T1 xenograft tumor growth, metastasis, and osteolytic lesions in vivo. Our study demonstrates that Atp6v1c1 may promote breast cancer growth and bone metastasis through regulation of lysosomal V-ATPase activity, indicating that Atp6v1c1 may be a viable target for breast cancer therapy and silencing of Atp6v1c1 may be an innovative therapeutic approach for the treatment and prevention of breast cancer growth and metastasis.

[1]  A. Vollmar,et al.  Mode of Cell Death Induction by Pharmacological Vacuolar H+-ATPase (V-ATPase) Inhibition* , 2012, The Journal of Biological Chemistry.

[2]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[3]  T. Yoneda,et al.  The a3 Isoform Vacuolar Type H+-ATPase Promotes Distant Metastasis in the Mouse B16 Melanoma Cells , 2011, Molecular Cancer Research.

[4]  Jon W. Huss,et al.  BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources , 2009, Genome Biology.

[5]  D. Esposito,et al.  Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma study , 2009, Pigment cell & melanoma research.

[6]  E. Brewer,et al.  Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells , 2009, Journal of cellular physiology.

[7]  L. Deng,et al.  Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts. , 2009, The Biochemical journal.

[8]  E. Otero-Rey,et al.  Intracellular pH regulation in oral squamous cell carcinoma is mediated by increased V-ATPase activity via over-expression of the ATP6V1C1 gene. , 2008, Oral oncology.

[9]  Michael Forgac,et al.  Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology , 2007, Nature Reviews Molecular Cell Biology.

[10]  M. Oursler,et al.  2-Methoxyestradiol suppresses osteolytic breast cancer tumor progression in vivo. , 2007, Cancer research.

[11]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[12]  M. Ishii,et al.  RGS18 Acts as a Negative Regulator of Osteoclastogenesis by Modulating the Acid‐Sensing OGR1/NFAT Signaling Pathway , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Y. St-Pierre,et al.  Acidic extracellular pH increases calcium influx‐triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase‐9 expression in mouse metastatic melanoma , 2007, The FEBS journal.

[14]  P. Matarrese,et al.  Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. , 2007, Cancer research.

[15]  N. Pavlos,et al.  Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis. , 2007, Histology and histopathology.

[16]  Hyunsook Kim,et al.  Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration. , 2007, International journal of molecular medicine.

[17]  J. Cooper,et al.  Cortactin has an essential and specific role in osteoclast actin assembly. , 2006, Molecular Biology of the Cell.

[18]  Aleksandra M. Michalowska,et al.  Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. , 2006, Cancer research.

[19]  P. Stern,et al.  In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes , 2006, Nature Genetics.

[20]  D. Hanahan,et al.  Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. , 2006, Genes & development.

[21]  G. Taraboletti,et al.  Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. , 2006, Neoplasia.

[22]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[23]  V. Trajković,et al.  Acidosis affects tumor cell survival through modulation of nitric oxide release. , 2006, Free radical biology & medicine.

[24]  Jinjun Li,et al.  The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. , 2005, Cancer research.

[25]  J. Foidart,et al.  Acidic Extracellular pH Induces Matrix Metalloproteinase-9 Expression in Mouse Metastatic Melanoma Cells through the Phospholipase D-Mitogen-activated Protein Kinase Signaling* , 2005, Journal of Biological Chemistry.

[26]  D. Hanahan,et al.  Multiple Roles for Cysteine Cathepsins in Cancer , 2004, Cell cycle.

[27]  K. Bakunts,et al.  Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. , 2004, American journal of physiology. Cell physiology.

[28]  D. Hanahan,et al.  Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. , 2004, Cancer cell.

[29]  T. Martin,et al.  A novel orthotopic model of breast cancer metastasis to bone , 1999, Clinical & Experimental Metastasis.

[30]  A. Yamamoto,et al.  Mouse Proton Pump ATPase C Subunit Isoforms (C2-a and C2-b) Specifically Expressed in Kidney and Lung* , 2003, Journal of Biological Chemistry.

[31]  William C Hahn,et al.  Lentivirus-delivered stable gene silencing by RNAi in primary cells. , 2003, RNA.

[32]  M. Futai,et al.  Diversity of mouse proton-translocating ATPase: presence of multiple isoforms of the C, d and G subunits. , 2003, Gene.

[33]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[34]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[35]  T. Martin,et al.  Mechanisms in the skeletal complications of breast cancer. , 2000, Endocrine-related cancer.

[36]  P. Kane,et al.  The H Subunit (Vma13p) of the Yeast V-ATPase Inhibits the ATPase Activity of Cytosolic V1 Complexes* , 2000, The Journal of Biological Chemistry.

[37]  J. Chirgwin,et al.  Molecular mechanisms of tumor-bone interactions in osteolytic metastases. , 2000, Critical reviews in eukaryotic gene expression.

[38]  Yuqiong Liang,et al.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification , 1999, Nature Genetics.

[39]  Ting Xu,et al.  Subunit Interactions in the Clathrin-coated Vesicle Vacuolar (H+)-ATPase Complex* , 1999, The Journal of Biological Chemistry.

[40]  M Forgac,et al.  Structure and Properties of the Vacuolar (H+)-ATPases* , 1999, The Journal of Biological Chemistry.

[41]  R. Gillies,et al.  pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. , 1999, Biochemical pharmacology.

[42]  M. Hendrix,et al.  Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential , 1998, Journal of cellular physiology.

[43]  P. Kane,et al.  Disassembly and reassembly of the yeast vacuolar H(+)-ATPase in vivo. , 1995, The Journal of biological chemistry.

[44]  J. Dow,et al.  Regulation of Plasma Membrane V-ATPase Activity by Dissociation of Peripheral Subunits (*) , 1995, The Journal of Biological Chemistry.

[45]  R. Gillies,et al.  Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. , 1993, The American journal of physiology.